Vital Exhaustion as a Risk Factor for Adverse Cardiac Events (from the Atherosclerosis Risk In Communities [ARIC] Study) by Williams, Janice E. et al.
Vital Exhaustion as a Risk Factor for Adverse Cardiac Events 
(From the Atherosclerosis Risk in Communities [ARIC] Study)
Janice E. Williams, PhD, MPHa, Thomas H. Mosley Jr., PhDb, Willem J. Kop, PhDc, David J. 
Couper, PhDd, Verna L. Welch, PhD, MPHe, and Wayne D. Rosamond, PhDf
aProgram in Public Health, LaGrange College, LaGrange, Georgia bDepartment of Medicine 
(Geriatrics), University of Mississippi Medical Center, Jackson, Mississippi cDivision of Cardiology, 
University of Maryland School of Medicine, Baltimore, Maryland dDepartment of Biostatistics, 
School of Public Health, University of North Carolina, Chapel Hill, North Carolina eDepartments of 
Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, 
Georgia fDepartment of Epidemiology, Gillings Global School of Public Health, University of North 
Carolina, Chapel Hill, North Carolina
Abstract
Vital exhaustion, defined as excessive fatigue, feelings of demoralization, and increased irritability, 
has been identified as a risk factor for incident and recurrent cardiac events, but there are no 
prospective studies of this association in United States samples. We examined the predictive value 
of vital exhaustion for incident myocardial infarction or fatal coronary heart disease (CHD) among 
middle-aged men and women in four US communities. Participants were 12,895 black or white 
men and women enrolled in the Atherosclerosis Risk In Communities (ARIC) Study cohort and 
followed for the occurrence of cardiac morbidity and mortality from 1990 through 2002 
(maximum follow-up = 13.0 years). Vital exhaustion was assessed using the 21-item Maastricht 
Questionnaire, and partitioned into approximate quartiles for statistical analyses. High vital 
exhaustion (the fourth quartile) predicted adverse cardiac events in age-, gender-, and race-center-
adjusted analyses (1.69 [95% C.I: 1.40 to 2.05]) and in analyses further adjusted for educational 
level, body mass index, plasma low density lipoprotein-and high density lipoprotein-cholesterol, 
systolic and diastolic blood pressure levels, diabetes mellitus, cigarette smoking status, and pack-
years of cigarette smoking (1.46 [95% C.I: 1.20 to 1.79]). The risk for adverse cardiac events 
increased monotonically from the first through the fourth quartile of vital exhaustion. The 
probabilities of adverse cardiac events over time were significantly higher in people with high vital 
exhaustion compared to those with low exhaustion (p = 0.002). In conclusion, vital exhaustion 
predicts the long-term risk for adverse cardiac events in men and women, independent of the 
established biomedical risk factors.
Correspondence Address: Janice E. Williams, PhD, MPH, Program in Public Health, LaGrange College, Post Office Box 3168, 
LaGrange, Georgia 30241; Telephone: (706) 884-2321; jwill22@bellsouth.net. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Am J Cardiol. Author manuscript; available in PMC 2016 June 30.
Published in final edited form as:














stress; risk factors; coronary disease; epidemiology
Even though support for a positive association between vital exhaustion - defined as a state 
of excessive fatigue, increased irritability, and demoralization - and coronary heart disease 
(CHD) has accumulated, most of the evidence has been derived from European populations. 
There are no prospective studies of vital exhaustion and acute coronary syndromes in United 
States samples. Using data from the Atherosclerosis Risk in Communities (ARIC) Study (1) 
cohort, the current analysis tested whether people with high vital exhaustion, compared to 
their low exhaustion counterparts, were at increased risk for incident MI and fatal CHD. The 
ARIC Study permitted a test of this hypothesis in a sample of middle-aged white or black 
men and women. We hypothesized that participants with high vital exhaustion, compared to 
their low exhaustion peers, would be at increased risk for adverse cardiac events and that a 
monotonic increase in risk from low to high exhaustion would be observed. The ARIC Study 
includes sufficient numbers of cardiac events to systematically examine the effects of vital 
exhaustion, adjusting for known predictors of cardiovascular disease progression.
 METHODS
Participants in this analysis were black or white men and women, aged 48 – 67, who were 
enrolled in the ARIC Study cohort at Visit 2 (1). ARIC is a large, population-based, 
prospective study of the etiology and natural history of atherosclerosis. A detailed 
description of study participants and research methodologies has been provided elsewhere 
(1). In brief, participants were selected through probability sampling from 4 U.S. 
communities of Washington County, Maryland; suburban Minneapolis, Minnesota; Forsyth 
County, North Carolina; and Jackson, Mississippi. In Jackson, Mississippi, only black 
participants were sampled. ARIC baseline examinations were obtained from 1987 to 1989 
(Visit 1), after which participants returned at approximately three-year intervals for three 
follow-up clinical examinations. Hospitalizations and deaths during the follow-up period 
were identified through annual telephone interviews and ongoing hospital surveillance. 
Participants for this analysis were the 14,348 ARIC cohort members (92.2%) who returned 
for the second clinic visit between 1990 and 1992 (Visit 2). Excluded from analyses were 
311 participants with missing data on prevalent CHD, 761 with prevalent CHD, 38 with a 
racial/ethnic identity other than black or white, 46 black participants from the Washington 
County, Maryland and suburban Minneapolis, Minnesota field centers (hence all black 
participants included in these analyses were enrolled in either Jackson, Mississippi or 
Forsyth County, North Carolina), and 297 with incomplete responses on the vital exhaustion 
questionnaire, resulting in a final sample of 12,895.
Vital exhaustion is defined as excessive fatigue, feelings of demoralization, and increased 
irritability and is often considered to be a form of adaptation to prolonged distress (2, 3). 
Vital exhaustion was assessed using the 21-item Maastricht Questionnaire (Appendix B) (2). 
Responses to the questionnaire are coded as: Yes = 2; Don’t know = 1; No = 0. Two items, 
questions 9 and 14, are reversed coded (Yes = 0; Don’t know = 1; No = 2). Responses are 
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summed to obtain an overall vital exhaustion score, which ranges from 0 – 42 with higher 
scores representing more exhaustion. Cronbach’s alpha for internal consistency has been 
reported as 0.89 (2).
At each clinic visit, participants were evaluated on a series of physiological and behavioral 
parameters. Trained technicians who used standardized protocols conducted the 
examinations. Participants reported information regarding cigarette smoking, race/ethnicity, 
and level of educational attainment. Blood pressure levels were assessed using a random-
zero sphygmomanometer after resting for five minutes. The average of the second and third 
of three consecutive measurements was used to calculate systolic and diastolic blood 
pressure levels. Hypertension was defined as diastolic blood pressure ≥ 90 mmHg, or 
systolic blood pressure ≥ 140 mmHg, or use of one or more antihypertensive medications 
within the past two weeks. High density lipoprotein (HDL) - cholesterol was measured 
enzymatically after precipitation of apolipoprotein B containing lipoproteins. Low density 
lipoprotein (LDL) - cholesterol was calculated using the Friedewald formula. Diabetes was 
defined as a fasting serum glucose level ≥ 126 mg/dL, a non-fasting serum glucose level ≥ 
200 mg/dL, and/or a history of diabetes, insulin therapy, or oral hypoglycemic medication 
use. Body mass index (BMI) was defined as weight divided by height squared (kg/m2).
Incident cardiac events (acute myocardial infarction or fatal CHD) were ascertained in the 
follow-up period from the participant’s clinic visit in 1990–1992 through December 31, 
2002 (average = 10.9 years; maximum = 13.0 years). Events were identified via annual 
telephone interviews and hospital surveillance and validated through abstraction of the 
medical record and death certificates. For in-hospital events, trained abstractors obtained 
from the medical record presenting symptoms, ECG readings, cardiac enzyme levels, and 
other supportive diagnostic indicators. A maximum of three 12-lead ECG tracings were 
submitted to the University of Minnesota ECG Reading Center where these data were 
interpreted using the Minnesota code. The criteria for myocardial infarction were based on a 
combination of chest pain, cardiac enzymes, ECG changes, and autopsy findings. The 
criteria for fatal CHD were based on a combination of chest pain, underlying diagnosis from 
the death certificate, and other supportive diagnostic indicators from the medical record. 
Additional information on out-of-hospital deaths was gathered from the decedent’s next of 
kin, the patient’s physician’s and/or the coroner’s or medical examiner’s report. Two 
physicians on the ARIC Morbidity and Mortality Classification Committee reviewed the 
documents and assigned the diagnosis; a third panel member adjudicated any discrepancies. 
Detailed descriptions of the procedures used in the ascertainment of cardiac events have 
been reported previously (1).
Means and percentages were used to describe the population in terms of baseline CHD risk 
factors by approximate quartiles of vital exhaustion. One-way analyses of variance were 
used to examine differences in means for continuous variables across quartiles; chi-squared 
tests were used to examine differences in proportions for categorical variables. Cox 
proportional hazards regression analyses were used to assess the effects of overall vital 
exhaustion and component depressive affect and fatigue on risk for adverse cardiac events. 
The covariates in the regression analyses were: age, race-center, cigarette smoking status, 
pack-years of smoking, level of educational attainment, gender, BMI, systolic and diastolic 
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blood pressure, plasma LDL- and HDL-cholesterol levels, and diabetes. Two models were 
fit, one adjusting for age, race-center, and gender and a second adjusting for all of the 
covariates. The Kaplan-Meier product limit method was used to estimate cumulative 
probabilities of adverse cardiac events over time. The log likelihood ratio test was used to 
assess differences in these probabilities across levels of exhaustion. All analyses were 
conducted using SAS version 8.2 (SAS Institute, Cary, NC).
 RESULTS
In the follow-up period from 1990 to 2002 (138,435 person-years), 802 incident cardiac 
events occurred, equivalent to a crude rate of 5.8 per 1,000 person-years. Mean vital 
exhaustion scores were significantly higher in women (12.1 [SD = 8.9]) than in men (7.9 
[SD = 7.6]) (p < 0.0001), and higher in black (12.2 [SD = 9.1]) than in white participants 
(9.7 [SD = 8.4]) (p < 0.0001). Vital exhaustion scores were positively skewed with an overall 
mean of 10.30 (SD = 8.6).
A baseline CHD risk factor profile indicated that participants in the highest quartile of vital 
exhaustion, compared to their peers in the lowest, were slightly older, heavier, and more 
likely to be female and black with a less than high school education. They also smoked more 
cigarettes, and were more likely to be diabetic and hypertensive, and to have higher systolic 
blood pressure and HDL-cholesterol levels. Most of these associations were markedly 
graded across quartiles of vital exhaustion (Table 1). Seventy-one percent of women in the 
cohort were postmenopausal, the majority of whom were in the lower quartiles of depressive 
affect. The prevalence of overall antidepressant and corticosteroid use was 4% and 1%, 
respectively.
The highest quartile of vital exhaustion predicted adverse cardiac events in age-, gender-, 
and race-center-adjusted analyses (Table 2). After additional adjustment for level of 
educational attainment, BMI, plasma LDL-and HDL-cholesterol, systolic and diastolic 
blood pressure levels, cigarette smoking status, pack-years of cigarette smoking, and 
diabetes, the HR was attenuated, but remained statistically significant (Table 2) (P - value for 
linear trend <0.0001, using the actual vital exhaustion scores). The effect estimate was not 
appreciably altered when antidepressant use was added to the model [1.43 (95% CI: 1.16 to 
1.77)]. The risk for adverse cardiac events increased monotonically from the lowest to the 
highest quartile of vital exhaustion. Kaplan-Meier product limit estimate of the cumulative 
probability of adverse cardiac events is depicted in Figure 1. The multivariate-adjusted HR 
was 1.56 (95% CI: 1.25 to 1.96) for the association between depressive affect and adverse 
cardiac events and 1.43 (95% CI: 1.18 to 1.74) for fatigue.
Results of log likelihood ratio tests indicated that adverse cardiac event-free survival was 
significantly shorter among participants in the highest compared to the third, second and first 
exhaustion quartiles (Figure 1). Survival was not significantly shorter among participants in 
the third compared to the first (P = 0.17) or second (P = 0.18) quartiles.
Williams et al. Page 4














In this analysis of men and women enrolled in the ARIC cohort, vital exhaustion predicted 
long-term risk for incident adverse cardiac events. These findings persisted after adjustment 
for the traditional biomedical CHD risk factors. Sociodemographically, vitally exhausted 
persons were slightly older and were more likely to be female and black with a less than 
high school education. They also had a more adverse vascular risk factor profile. These 
results confirm prospective reports of a positive association between vital exhaustion and 
incident CHD previously observed in European samples. They indicate that excessive 
fatigue, feelings of demoralization, and increased irritability are important precursors to 
adverse cardiac events.
The biological mechanism that links vital exhaustion to adverse cardiac events is not well 
understood. Vital exhaustion is associated with a number of metabolic, hemodynamic, and 
immune responses that are known to be important for the development and progression of 
cardiovascular disease. Included among them are: abnormal lipid metabolism (4), decreased 
fibrinolysis and increased coagulation (5, 6), diurnal variations in fibrinolysis and 
coagulation (7), and low heart rate variability (8). Vital exhaustion is also associated with 
increased immune-mediated inflammation, which is a key factor in atherosclerosis. In a 
sample of healthy middle-aged men, associations between vital exhaustion, lower 
glucocorticoid sensitivity, and a failure of the glucocorticoids to inhibit the release of IL-6 
were documented (9). In other investigations, vitally exhausted persons, compared to their 
nonexhausted peers, were observed to have higher levels of proinflammatory cytokines, 
specifically IL-6 (10), IL-1β (11), and TNF-α (12), and higher levels of C-reactive protein, a 
nonspecific marker of inflammation (12). The hypothalamic-pituitary adrenocortical axis 
(HPA), which responds to long-term stress with an attenuation of cortisol, has been 
implicated as an underlying mechanism (13). Support for this hypothesis has been found in 
studies that have documented an association of vital exhaustion with alterations in the 
negative feedback sensitivity of the HPA axis and suppression of HPA basal activity (14, 
15).
Another important observation from this analysis was that vitally exhausted participants, 
compared to their nonexhausted peers, were more likely to be female, black and less 
formally educated, which collectively suggests a social disadvantage in exhaustion. Our 
findings are consistent with those of previous studies showing that exhaustion is commonly 
reported among women (16, 17), and with those in which women have reported greater 
levels of exhaustion than men (18, 19). It is important to note that exhaustion is a common 
precursor to MI among women. In a recent study, a preponderance of women (70.7%) 
reported unusual fatigue as compared with a much smaller proportion (29.7%) reporting 
typical angina symptoms in the prodromal period of MI (20). In the acute phase of MI, 
42.9% of women reported fatigue and 54.8% reported weakness. Our findings also confirm a 
previously observed inverse association between exhaustion and socioeconomic status (SES) 
(18). However, ours is the first report of higher exhaustion in blacks compared to whites. 
These associations may be understood in view of the fact that people in the lower SES strata 
(21) and blacks (22), compared to their middle and upper SES and white counterparts, 
respectively, report more chronic stress.
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Vital exhaustion is closely linked to depression, as they have some common characteristics, 
such as fatigue and irritability. However, it is unclear whether depression and vital 
exhaustion are conceptually distinct or variations on a theme. Several empirical studies bear 
on this question, reporting differences in symptomatology (23), differences in the 
relationship of vital exhaustion and depression to CHD risk factors (24), yet strong positive 
correlations between these two constructs (25). In an investigation among patients who had 
undergone percutaneous coronary intervention, the effects of overall vital exhaustion and 
component depressive symptoms, fatigue, and hopelessness were examined as predictors of 
all-cause mortality and nonfatal MI (26). Depressive symptoms was the only significant 
predictor of adverse cardiac events in this sample of patients with established CHD, and 
within the depression spectrum, hopelessness was key. In the current analyses, component 
depressive affect and fatigue each significantly predicted adverse cardiac events and the 
magnitude of association was stronger for depressive affect.
Comparable relative risks have been reported for the association between clinical depression 
and vital exhaustion, and incident CHD. Two meta-analyses (27, 28) reported an overall 
relative risk of 1.64 for the association between depression (including clinical depression 
and subclinical depression) and incident CHD. When clinical depression and depressive 
mood were considered separately, the effect estimate was larger for clinical depression 
(RR=2.69) than depressive mood (RR = 1.49) (26). To our knowledge, a meta-analysis of 
vital exhaustion has not been published. However, relative risks reported in previous studies 
have been comparable to those for clinical depression – being 2.07 among male college 
alumni (29), 2.75 among hospitalized women (30), and 2.57 and 2.51, respectively, in a 
community sample of women and men (18).
The strengths and weaknesses of this analysis warrant discussion. ARIC employed a well-
known, reliable instrument to assess exhaustion. However, this does not remove the potential 
for response biases in these self-reported data, most notably errors arising from social 
desirability and inaccuracies resulting from poor recall. Further, adverse cardiac events were 
validated using standardized criteria. In the analyses, we controlled for the effect of the 
established CHD risk factors on the relationship between vital exhaustion and cardiac risk, 
but there could have been residual confounding by unmeasured risk factors. Traditionally, 
black participants have been underrepresented in studies of psychosocial factors in CHD 
risk. The inclusion of a large bi-ethnic United States cohort of black or white men and 
women in the ARIC study begins to fill this gap. The prospective design of this analysis 
provides strong evidence of a positive association between vital exhaustion and adverse 
cardiac events in a population-based cohort study. Long-term follow-up permitted an 
examination of its effect over a 13-year period, thus documenting long-term predictive value.
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 Appendix A. The Maastricht Questionnaire
1. Do you often feel tired? (F)
2. Do you often have trouble falling asleep? (D)
3. Do you wake up repeatedly during the night? (D)
4. Do you feel weak all over? (F)
5. Do you have the feeling that you haven’t been accomplishing much lately? (F)
6. Do you have the feeling that you can’t cope with everyday problems as well as 
you used to? (F)
7. Do you believe that you have come to a “dead end”? (D)
8. Do you lately feel more listless than before? (F)
9. I enjoy sex as much as ever. (F)
10. Have you experienced a feeling of hopelessness recently? (D)
11. Does it take more time to grasp a difficult problem than it did a year ago? (F)
12. Do little things irritate you more lately than they used to?
13. Do you feel you want to give up trying?
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14. I feel fine. (F)
15. Do you sometimes feel that your body is like a battery that is losing its power? 
(F)
16. Would you want to be dead at times? (D)
17. Do you have the feeling these days that you just don’t have what it takes any 
more? (F)
18. Do you feel dejected? (D)
19. Do you feel like crying sometimes? (D)
20. Do you ever wake up with a feeling of exhaustion and fatigue? (F)
21. Do you have increasing difficulty in concentrating on a single subject for long? 
(F)
F - Fatigue D - Depressive affect
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The Kaplan-Meier product limit estimate of the cumulative probability of adverse cardiac 
events by level of vital exhaustion (P = 0.01, 0.0005, 0.002 for differences between Q4 and 
Q3, Q2, and Q1, respectively).
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Table 2
Hazard Ratios (95% Confidence Interval) for the Association Between Vital Exhaustion and Adverse Cardiac 
Events, The ARIC Study, 2002
Regression Models
Number of incident events = 800
Model 1a Hazard Ratios P-value
  Exhaustion Q1 (Reference) 1.00
  Exhaustion Q2 1.08 (0.88 – 1.33) 0.45
  Exhaustion Q3 1.28 (1.06 – 1.56) 0.01
  Exhaustion Q4 1.69 (1.40 – 2.05) <0.0001
Model 2b
  Exhaustion Q1 (Reference) 1.00
  Exhaustion Q2 1.02 (0.82 – 1.27) 0.84
  Exhaustion Q3 1.18 (0.97 – 1.45) 0.10
  Exhaustion Q4 1.46 (1.20 – 1.79) 0.0002
a
Adjusted for age, gender, race-center
b
Adjusted for age, gender, race-center, educational level, diastolic and systolic blood pressure levels, diabetes mellitus, body mass index, low 
density lipoprotein- and high density lipoprotein cholesterol levels, cigarette smoking status, pack-years of cigarette smoking
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